ticagrelor 60 MG Oral Tablet [Brilinta]

RxNorm concept 1666334, branded drug (sbd). Prescribable name: BRILINTA (ticagrelor) 60 MG Oral Tablet.

RxCUI: 1666334
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1666334 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

ticagrelor 1116632

Other names

Brilinta 60 MG Oral Tablet

Related concepts

ticagrelor 60 MG (SCDC, consists of)
ticagrelor 60 MG [Brilinta] (SBDC, consists of)
Oral Tablet (DF, has dose form)
Brilinta (BN, has ingredient)
ticagrelor 60 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1666334 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1666334 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1666334. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.